GSK unveils new branding and logo to showcase 'transformed' business
As GlaxoSmithKline becomes GSK and sheds its consumer unit, the British Big Pharma has revealed new branding, a tech-flavored logo and a “transformative”...
Breakingviews - GSK castoff starts life with target on its back
GlaxoSmithKline's personal health spinoff is beginning life with a target on its back. Haleon, maker of Advil painkillers and Sensodyne...
GSK hopes for boost from respiratory virus jab
GlaxoSmithKline will apply for approval for its respiratory syncytial virus vaccine for older adults, after reporting data showing the shot...
Respiratory Syncytial Virus: GSK RSV Vaccine Delivers Positive Trial Results
GSK Plc said its vaccine targeting a respiratory virus that causes hundreds of thousands of hospitalizations in older adults each year...
Miners drag UK'S FTSE 100 lower after hawkish ECB; GSK rises
UK's top stock index fell nearly 1% on Friday, with miners leading the losses after parts of Shanghai announced fresh COVID-19 curbs,...
Wolff Olins overhauls GSK's identity
The new identity is inspired by biosciences imagery and aims to better express GSK's diversity and focus on innovation.
GlaxoSmithKline (GSK) Stock Moves -0.11%: What You Should Know
GlaxoSmithKline (GSK) closed at $44.20 in the latest trading session, marking a -0.11% move from the prior day. This change was narrower...
Pfizer to exit GSK consumer health joint venture after London listing
Pfizer will sell down its stake in Haleon, its consumer health joint venture with GlaxoSmithKline, after a London listing planned for July...
GSK spin-off will trigger pay bonanza: Boss of new arm in line for £10m
Haleon is due to be spun out from GSK next month and begin trading on the London Stock Exchange on July 18.
GSK to buy US biotech group Affinivax in $3bn deal
GlaxoSmithKline is buying Boston-based biotech Affinivax in a transaction worth up to $3.3bn, bolstering its vaccines business with new...
Comments